132 related articles for article (PubMed ID: 38909741)
21. Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.
Angelilli A; Ritch R
Middle East Afr J Ophthalmol; 2009 Jan; 16(1):35-40. PubMed ID: 20142958
[TBL] [Abstract][Full Text] [Related]
22. Validation of genetically matched wild-type strain and lysyl oxidase-like 1 knockout mouse model of pelvic organ prolapse.
Couri BM; Borazjani A; Lenis AT; Balog B; Kuang M; Lin DL; Damaser MS
Female Pelvic Med Reconstr Surg; 2014; 20(5):287-92. PubMed ID: 25181380
[TBL] [Abstract][Full Text] [Related]
23. Review: The role of LOXL1 in exfoliation syndrome/glaucoma.
Whigham BT; Allingham RR
Saudi J Ophthalmol; 2011 Oct; 25(4):347-52. PubMed ID: 23960948
[TBL] [Abstract][Full Text] [Related]
24. Genetic background determines severity of Loxl1-mediated systemic and ocular elastosis in mice.
Suarez MF; Schmitt HM; Kuhn MS; Watkins T; Hake KM; Weisz T; Flynn EJ; Elliott MH; Hauser MA; Stamer WD
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 37905384
[TBL] [Abstract][Full Text] [Related]
25. Male Marfan mice are predisposed to high-fat diet-induced obesity, diabetes, and fatty liver.
Tiedemann K; Muthu ML; Reinhardt DP; Komarova SV
Am J Physiol Cell Physiol; 2022 Aug; 323(2):C354-C366. PubMed ID: 35759435
[TBL] [Abstract][Full Text] [Related]
26. Lyst mutation in mice recapitulates iris defects of human exfoliation syndrome.
Trantow CM; Mao M; Petersen GE; Alward EM; Alward WL; Fingert JH; Anderson MG
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1205-14. PubMed ID: 19029039
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants and cellular stressors associated with exfoliation syndrome modulate promoter activity of a lncRNA within the LOXL1 locus.
Hauser MA; Aboobakar IF; Liu Y; Miura S; Whigham BT; Challa P; Wheeler J; Williams A; Santiago-Turla C; Qin X; Rautenbach RM; Ziskind A; Ramsay M; Uebe S; Song L; Safi A; Vithana EN; Mizoguchi T; Nakano S; Kubota T; Hayashi K; Manabe S; Kazama S; Mori Y; Miyata K; Yoshimura N; Reis A; Crawford GE; Pasutto F; Carmichael TR; Williams SE; Ozaki M; Aung T; Khor CC; Stamer WD; Ashley-Koch AE; Allingham RR
Hum Mol Genet; 2015 Nov; 24(22):6552-63. PubMed ID: 26307087
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese.
Fuse N; Miyazawa A; Nakazawa T; Mengkegale M; Otomo T; Nishida K
Mol Vis; 2008 Jul; 14():1338-43. PubMed ID: 18648524
[TBL] [Abstract][Full Text] [Related]
29. The association of LOXL1 polymorphisms with exfoliation syndrome/glaucoma: Meta-analysis.
Ji QS; Qi B; Wen YC; Liu L; Guo XL; Yu GC; Zhong JX
Int J Ophthalmol; 2015; 8(1):148-56. PubMed ID: 25709925
[TBL] [Abstract][Full Text] [Related]
30. Exfoliation syndrome: assembling the puzzle pieces.
Pasquale LR; Borrás T; Fingert JH; Wiggs JL; Ritch R
Acta Ophthalmol; 2016 Sep; 94(6):e505-12. PubMed ID: 26648185
[TBL] [Abstract][Full Text] [Related]
31. Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking lysyl oxidase-like 1 (LOXL1).
Wiggs JL; Pawlyk B; Connolly E; Adamian M; Miller JW; Pasquale LR; Haddadin RI; Grosskreutz CL; Rhee DJ; Li T
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):856-64. PubMed ID: 24425853
[TBL] [Abstract][Full Text] [Related]
32. The T allele of lysyl oxidase-like 1 rs41435250 is a novel risk factor for pseudoexfoliation syndrome and pseudoexfoliation glaucoma independently and through intragenic epistatic interaction.
Guadarrama-Vallejo D; Miranda-Duarte A; Zenteno JC
Mol Vis; 2013; 19():1937-44. PubMed ID: 24068861
[TBL] [Abstract][Full Text] [Related]
33. Association between Obstructive Sleep Apnea and Exfoliation Syndrome: The Utah Project on Exfoliation Syndrome.
Shumway C; Curtin K; Taylor S; Sundar KM; Wirostko BM; Ritch R
Ophthalmol Glaucoma; 2021; 4(3):260-267. PubMed ID: 33007491
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical Profiles of LOXL-1, FBN1, TGF-β1, and COX-2 in Pseudoexfoliation Syndrome.
Papadopoulou M; Papadaki H; Zolota V; Gartaganis SP
Curr Eye Res; 2017 Jun; 42(6):880-889. PubMed ID: 28085506
[TBL] [Abstract][Full Text] [Related]
35. Fibrillin-1 regulates white adipose tissue development, homeostasis, and function.
Muthu ML; Tiedemann K; Fradette J; Komarova S; Reinhardt DP
Matrix Biol; 2022 Jun; 110():106-128. PubMed ID: 35533973
[TBL] [Abstract][Full Text] [Related]
36. LOXL1 gene polymorphisms are associated with exfoliation syndrome/exfoliation glaucoma risk: An updated meta-analysis.
Li X; He J; Sun J
PLoS One; 2021; 16(4):e0250772. PubMed ID: 33909695
[TBL] [Abstract][Full Text] [Related]
37. Multiple Gene Polymorphisms Associated with Exfoliation Syndrome in the Uygur Population.
Ma YN; Xie TY; Chen XY
J Ophthalmol; 2019; 2019():9687823. PubMed ID: 31192002
[TBL] [Abstract][Full Text] [Related]
38. Mice with an induced mutation in collagen 8A2 develop larger eyes and are resistant to retinal ganglion cell damage in an experimental glaucoma model.
Steinhart MR; Cone FE; Nguyen C; Nguyen TD; Pease ME; Puk O; Graw J; Oglesby EN; Quigley HA
Mol Vis; 2012; 18():1093-106. PubMed ID: 22701298
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population.
Chen L; Jia L; Wang N; Tang G; Zhang C; Fan S; Liu W; Meng H; Zeng W; Liu N; Wang H; Jia H
Mol Vis; 2009 Nov; 15():2349-57. PubMed ID: 19936304
[TBL] [Abstract][Full Text] [Related]
40. DNA Polymorphism of the
Ma Y; Yang M; Chen X; Yi X
J Ophthalmol; 2022; 2022():9342635. PubMed ID: 35942063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
